Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 242

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis

Open access
Petrovski, Slavé, Todd, Jamie L., Durheim, Michael T., Wang, Quanli, Chien, Jason W., Kelly, Fran L., Frankel, Courtney, Mebane, Caroline M., Ren, Zhong, Bridgers, Joshua, Urban, Thomas J., Malone, Colin D., Finlen Copeland, Ashley, Brinkley, Christie, Allen, Andrew S., O’Riordan, Thomas, McHutchison, John G., Palmer, Scott M., Goldstein, David B. · 2017 · American Journal of Respiratory and Critical Care Medicine

Abstract

Abstract Rationale Idiopathic pulmonary fibrosis (IPF) is an increasingly recognized, often fatal lung disease of unknown etiology. Objectives The aim of this study was to use whole-exome sequencing to improve understanding of the genetic architecture of pulmonary fibrosis. Methods We performed a case–control exome-wide collapsing analysis including 262 unrelated individuals with pulmonary fibrosis clinically classified as IPF according to American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Association guidelines (81.3%), usual interstitial pneumonia secondary to autoimmune conditions (11.5%), or fibrosing nonspecific interstitial pneumonia (7.2%). The majority (87%) of case subjects reported no family history of pulmonary fibrosis. Measurements and Main Results We searched 18,668 protein-coding genes for an excess of rare deleterious genetic variation using whole-exome sequence data from 262 case subjects with pulmonary fibrosis and 4,141 control subjects drawn from among a set of individuals of European ancestry. Comparing genetic variation across 18,668 protein-coding genes, we found a study-wide significant (P < 4.5 × 10−7) case enrichment of qualifying variants in TERT, RTEL1, and PARN. A model qualifying ultrarare, deleterious, nonsynonymous variants implicated TERT and RTEL1, and a model specifically qualifying loss-of-function variants implicated RTEL1 and PARN. A subanalysis of 186 case subjects with sporadic IPF confirmed TERT, RTEL1, and PARN as study-wide significant contributors to sporadic IPF. Collectively, 11.3% of case subjects with sporadic IPF carried a qualifying variant in one of these three genes compared with the 0.3% carrier rate observed among control subjects (odds ratio, 47.7; 95% confidence interval, 21.5–111.6; P = 5.5 × 10−22). Conclusions We identified TERT, RTEL1, and PARN—three telomere-related genes previously implicated in familial pulmonary fibrosis—as significant contributors to sporadic IPF. These results support the idea that telomere dysfunction is involved in IPF pathogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201610-2088oc

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 242

Metadata

Authors
Petrovski, S., Todd, J. L., Durheim, M. T., Wang, Q., Chien, J. W., Kelly, F. L., Frankel, C., Mebane, C. M., Ren, Z., Bridgers, J., Urban, T. J., Malone, C. D., Finlen Copeland, A., Brinkley, C., Allen, A. S., O’Riordan, T., McHutchison, J. G., Palmer, S. M., & Goldstein, D. B.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2017-07-01
Volume
196
Issue
1
Pages
82-93
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2581927130
Cited by
242
References
16
FWCI
21.06
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis. https://app.cochat.ai/papers/10.1164/rccm.201610-2088oc
The paper
Petrovski, S., Todd, J. L., Durheim, M. T., Wang, Q., Chien, J. W., Kelly, F. L., Frankel, C., Mebane, C. M., Ren, Z., Bridgers, J., Urban, T. J., Malone, C. D., Finlen Copeland, A., Brinkley, C., Allen, A. S., O’Riordan, T., McHutchison, J. G., Palmer, S. M., & Goldstein, D. B. (2017). An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201610-2088oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.